Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2022

The activity for stock options under the Company’s stock plans for the three months ended March 31, 2022 is as follows:

							Remaining
							weighted-
					Weighted-		average		Per share
					average		contractual		average
				Price per	exercise		terms		intrinsic
	Options			share	price		(in years)		value
Outstanding as of December 31, 2021		459,441		$1.17-$83.30	$	42.18		1.36	$	4.31
Exercised		(3,499	)	8.37		8.37
Forfeited		(7,500	)	38.54-44.19		42.31
Outstanding as of March 31, 2022		448,442		1.17-83.30		42.44		1.04		3.97
Vested and exercisable as of March 31, 2022		448,442		1.17-83.30		42.44		1.04		3.97
Vested and expected to vest as of March 31, 2022		448,442		$1.17-$83.30	$	42.44		1.04	$	3.97

Summary of Restricted Stock Activity

Stock Awards activity for the three months ended March 31, 2022 is summarized below:

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock units	Time-based			time-based			Total			per share
Unvested restricted stock units as of December 31, 2021		289,166			99,112			388,278		$	54.81
Granted		304,975			164,722			469,697			35.32
Vested		(63,388	)		(37,677	)		(101,065	)		53.98
Forfeited/canceled		(9,042	)		—			(9,042	)		47.16
Unvested restricted stock units as of March 31, 2022 ⁽¹⁾		521,711			226,157			747,868		$	43.27
Unvested and expected to vest restricted stock units outstanding as of March 31, 2022								568,034		$	43.27

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock awards	Time-based			time-based			Total			per share
Unvested restricted stock awards outstanding as of December 31, 2021		10,416			5,629			16,045		$	87.12
Vested		(2,111	)		(5,629	)		(7,740	)		103.09
Unvested restricted stock awards outstanding as of March 31, 2022 ⁽¹⁾		8,305			—			8,305		$	76.71
Unvested and expected to vest restricted stock awards outstanding as of March 31, 2022								7,922		$	77.34

(1)	Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three months ended March 31, 2022 and March 31, 2021, was as follows:

	Three months ended
	March 31,
	2022		2021
Stock-based compensation expense by type of award:
Restricted stock units and restricted stock awards		2,468	$	2,330
Employee stock purchase plan		197		186
Total stock-based compensation expense	$	2,665	$	2,516

For the three months ended March 31, 2022 and March 31, 2021, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

	Three months ended
	March 31,
	2022		2021
Cost of revenue	$	233	$	238
Research and development		384		298
Sales and marketing		591		612
General and administrative		1,457		1,368
Total stock-based compensation expense	$	2,665	$	2,516